Form 4 holding
President, CMO
Prelude Therapeutics Inc
- Security class
- Common Stock
- Shares / value
- 86,917
- Estimated value
- $127,767
- Report date
- 04 Oct 2025
- Price
- $1.47
- Ownership
- Direct
Jane Huang - President, CMO at Prelude Therapeutics Inc
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- President, CMO
- Issuer Symbol
- PRLD on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Jane Huang since 17 May 2025
Holdings reported by Jane Huang for Prelude Therapeutics Inc
Form 4 holding
President, CMO
Prelude Therapeutics Inc
- Security class
- Restricted Stock Unit
- Shares / value
- 18,750
- Estimated value
- $25,969
- Report date
- 04 Oct 2025
- Price
- $0.6925
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President, CMO
Prelude Therapeutics Inc
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 200,000
- Estimated value
- Report date
- 04 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Jane Huang for Prelude Therapeutics Inc
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.